Keynote 024 5 Year Old

Keynote 024 5 Year Old. The pembrolizumab/pemetrexed/platinum combination reduced the risk of disease progression or death vs chemotherapy alone, with an almost double median.


Keynote 024 5 Year Old

The pembrolizumab/pemetrexed/platinum combination reduced the risk of disease progression or death vs chemotherapy alone, with an almost double median.

Keynote 024 5 Year Old Images References :